Unpacking the mRNA Supply Chain: Challenges and Opportunities for Global Health

Area of Science:

• Biotechnology
• Vaccinology
• Supply Chain Management

Background:

• mRNA vaccines demonstrated significant potential during the COVID-19 pandemic.
• Their unique manufacturing requires specialized raw materials (e.g., plasmid DNA, lipid nanoparticles) from limited global suppliers.
• Stringent cold chain requirements and platform-specific processes create supply chain vulnerabilities.

Purpose of the Study:

• To examine the distinctive features of mRNA vaccine supply chains.
• To identify key challenges and opportunities in manufacturing, logistics, and regulatory governance.
• To synthesize evidence on supply chain bottlenecks and propose strategies for strengthening resilience.

Main Methods:

• Narrative review of literature published between January 2021 and March 2026.
• Analysis of supply chain bottlenecks, including raw material dependencies, manufacturing scale-up limitations, cold chain constraints, and regulatory fragmentation.
• Focus on implications for low- and middle-income countries.

Main Results:

• Identified upstream dependencies, manufacturing scale-up issues, cold chain limitations, and regulatory fragmentation as key bottlenecks.
• Highlighted the disproportionate impact of these challenges on low- and middle-income countries.
• Documented emerging strategies such as supplier diversification, regional manufacturing, improved thermostability, regulatory harmonization, and digital supply chain management.

Conclusions:

• mRNA vaccine supply chains face structural challenges demanding multifaceted solutions.
• Strengthening resilience requires addressing manufacturing, logistics, and regulatory domains collaboratively.
• Proactive strategies are crucial for global preparedness in future health emergencies.